您的位置: 首页 > 农业专利 > 详情页

ANTICORPS MONOCLONAUX DE CSPG4 UTILISES DANS LE DIAGNOSTIC ET LE TRAITEMENT DU CARCINOME MAMMAIRE DE TYPE BASAL
专利权人:
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
发明人:
FERRONE, SOLDANO,WANG, XINHUI
申请号:
CA2737758
公开号:
CA2737758C
申请日:
2009.09.18
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
It is disclosed herein that condroitin sulfate proteoglycan 4 (CSPG4), alsoknown as high molecular weightmelanomal associated antigen, is overexpressed on basal breast carcinoma cells(BBC), specifically triple negative basal breastcarcinoma cells (TNBC). Methods for detecting basal breast cancer in a subjectare disclosed. Methods are also disclosed for inhibitingthe growth of a basal breast cancer cell. These methods include contacting thebasal breast cancer cancer cell with an effectiveamount of an antibody that specifically binds CSPG4. Additional treatmentmethods, and the use of antibody panels, arealso described herein.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充